The approval status of PAXLOVID varies worldwide

Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.
April 21, 2022

The approval status of PAXLOVID varies worldwide, Pfizer does not suggest or recommend the use of our products in any other manner other than described in the Prescribing Information/ Factsheet/ EUA/ Conditional Approval. Please refer to the Prescribing Information/ Factsheet/ EUA/ Conditional Approval for important treatment considerations.

Paxlovid™ (Nirmatrelvir (PF-07321332))/Ritonavir)